Objective:

To demonstrate the effectiveness of a percutaneous extracorporeal ventricular assist device (VAD) as a transitional solution for patients with refractory cardiogenic shock (CS) awaiting durable left ventricular assist device (LVAD) implantation, particularly in settings with limited surgical options.

Key Findings:

• The percutaneous extracorporeal VAD was successfully implemented without complications, despite the patient's initial critical condition.
• The patient showed rapid improvement and was able to undergo durable LVAD implantation after 215 hours of support.
• This technique alleviates left ventricular load and reduces complications associated with traditional methods.

Interpretation:

The use of a minimally invasive extracorporeal VAD provides a viable bridging strategy for patients in severe cardiogenic shock, particularly in settings with limited access to advanced surgical options, though further studies are needed to validate these findings.

Limitations:

• The case study is based on a single patient, limiting generalizability.
• Further studies are needed to assess long-term outcomes and efficacy across diverse patient populations, including those with varying comorbidities.

Conclusion:

The percutaneous extracorporeal VAD represents a promising approach for managing refractory cardiogenic shock, facilitating timely intervention and improving patient outcomes, especially in resource-limited settings.